Mizuho Increases UnitedHealth Group (NYSE:UNH) Price Target to $650.00

UnitedHealth Group (NYSE:UNH) had its price objective boosted by investment analysts at Mizuho from $600.00 to $650.00 in a research note issued on Wednesday,Benzinga reports. The firm currently has an “outperform” rating on the healthcare conglomerate’s stock. Mizuho’s price target indicates a potential upside of 9.23% from the stock’s previous close.

Other equities research analysts have also issued reports about the stock. Barclays reduced their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research note on Friday, January 17th. HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target for the company in a report on Friday, January 10th. KeyCorp restated an “overweight” rating and set a $650.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. Truist Financial cut their price target on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Finally, Piper Sandler dropped their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research report on Thursday, January 2nd. Twenty-one investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Buy” and an average price target of $630.35.

UnitedHealth Group Trading Up 2.9 %

UNH opened at $595.07 on Wednesday. The firm has a market capitalization of $544.32 billion, a price-to-earnings ratio of 38.39, a PEG ratio of 1.37 and a beta of 0.61. The company’s 50 day moving average price is $511.79 and its two-hundred day moving average price is $541.87. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group has a fifty-two week low of $436.38 and a fifty-two week high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the previous year, the business earned $5.83 EPS. The business’s quarterly revenue was up 6.8% compared to the same quarter last year. As a group, research analysts predict that UnitedHealth Group will post 29.54 earnings per share for the current year.

Insider Activity

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the firm’s stock in a transaction that occurred on Friday, January 17th. The stock was acquired at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 0.33% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On UnitedHealth Group

Several large investors have recently modified their holdings of UNH. Breakwater Capital Group increased its position in UnitedHealth Group by 18.0% in the first quarter. Breakwater Capital Group now owns 2,890 shares of the healthcare conglomerate’s stock worth $1,514,000 after buying an additional 440 shares during the last quarter. Retirement Planning Group LLC raised its stake in UnitedHealth Group by 5.1% in the 1st quarter. Retirement Planning Group LLC now owns 430 shares of the healthcare conglomerate’s stock valued at $225,000 after acquiring an additional 21 shares during the period. Chesley Taft & Associates LLC boosted its position in UnitedHealth Group by 5.6% during the first quarter. Chesley Taft & Associates LLC now owns 33,931 shares of the healthcare conglomerate’s stock worth $17,771,000 after purchasing an additional 1,802 shares during the period. Thurston Springer Miller Herd & Titak Inc. raised its position in shares of UnitedHealth Group by 20.8% in the first quarter. Thurston Springer Miller Herd & Titak Inc. now owns 4,976 shares of the healthcare conglomerate’s stock valued at $2,606,000 after purchasing an additional 858 shares during the period. Finally, Lake Street Private Wealth LLC grew its stake in UnitedHealth Group by 257.8% in the 1st quarter. Lake Street Private Wealth LLC now owns 5,084 shares of the healthcare conglomerate’s stock valued at $2,663,000 after buying an additional 3,663 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.